Literature DB >> 2226102

Cirrhosis of the liver. A risk factor for development of cholelithiasis in males.

F Fornari1, G Civardi, E Buscarini, L Cavanna, D Imberti, S Rossi, G Sbolli, M Di Stasi, L Buscarini.   

Abstract

An ultrasonographic study about the prevalence of cholelithiasis was performed in 410 cirrhotic patients and in 414 controls matched for age and sex. Gallstone disease was found more often in cirrhotic patients (31.9%) than in controls (20.7%) (P less than 0.001). The female-to-male ratio of gallstones prevalence in cirrhotic patients approached to 1:1. Gallstone disease in cirrhotic patients vs controls was significantly higher (30.2% vs 16.5%) (P less than 0.001) in males only. No difference was found, for gallstone disease prevalence in cirrhosis of different etiology. The prevalence of cholelithiasis increased from Child's A to Child's C with a significant trend (P less than 0.001); this difference was significant in males (12.3% vs 40.5%) (P less than 0.001) but not in females. This study shows that cirrhosis represents a risk factor for the development of cholelithiasis in males. We suggest that high levels of estrogens could play a role in these patients, by an impairment of gallbladder emptying similar to that observed in pregnant women.

Entities:  

Mesh:

Year:  1990        PMID: 2226102     DOI: 10.1007/bf01536748

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

1.  [Evaluation of gallbladder emptying in patients with chronic liver disease by 99mTc-EHIDA hepatobiliary scintigraphy].

Authors:  N Kurihara; H Ide; T Omata; S Yonamine; Y Mashima; M Tanno; K Chiba; H Yamada
Journal:  Radioisotopes       Date:  1989-06

2.  Ultrasonographic study of gallbladder motility during total parenteral nutrition.

Authors:  N Cano; F Cicero; F Ranieri; J Martin; J di Costanzo
Journal:  Gastroenterology       Date:  1986-08       Impact factor: 22.682

3.  Gall bladder sludge formation during prolonged fasting after gastrointestinal tract surgery.

Authors:  L Bolondi; S Gaiani; S Testa; G Labò
Journal:  Gut       Date:  1985-07       Impact factor: 23.059

4.  Diet, alcohol, and relative weight in gall stone disease: a case-control study.

Authors:  R K Scragg; A J McMichael; P A Baghurst
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-14

5.  Cirrhosis and alcoholism as pathogenetic factors in pigment gallstone formation.

Authors:  W H Schwesinger; W E Kurtin; B A Levine; C P Page
Journal:  Ann Surg       Date:  1985-03       Impact factor: 12.969

6.  Routine sonographic techniques fail to quantify gallstone size and number: a retrospective study of 111 surgically proved cases.

Authors:  J A Brink; J F Simeone; P R Mueller; S Saini; G A Tung; N O Spell; J T Ferrucci
Journal:  AJR Am J Roentgenol       Date:  1989-09       Impact factor: 3.959

7.  Incidence of cholelithiasis among patients with cirrhosis and portal hypertension.

Authors:  H V Steinberg; W W Beckett; J L Chezmar; W E Torres; F B Murphy; M E Bernardino
Journal:  Gastrointest Radiol       Date:  1988-10

8.  The prevalence and incidence of cholecystolithiasis in patients with chronic liver diseases: a prospective study.

Authors:  I S Sheen; Y F Liaw
Journal:  Hepatology       Date:  1989-04       Impact factor: 17.425

9.  [The frequency of gallstones in liver cirrhosis (author's transl)].

Authors:  H Goebell; H D Rudolph; N Breuer; W Hartmann; H D Leder
Journal:  Z Gastroenterol       Date:  1981-07       Impact factor: 2.000

10.  Natural history of cholelithiasis in patients with alcoholic cirrhosis (cholelithiasis in cirrhotic patients).

Authors:  G Dunnington; E Alfrey; R Sampliner; F Kogan; C Putnam
Journal:  Ann Surg       Date:  1987-03       Impact factor: 12.969

View more
  16 in total

1.  Concept of the pathogenesis and treatment of cholelithiasis.

Authors:  Vasiliy Ivanovich Reshetnyak
Journal:  World J Hepatol       Date:  2012-02-27

2.  Evaluation of gallbladder motility in patients with liver cirrhosis: relationship to gallstone formation.

Authors:  C P Li; S J Hwang; F Y Lee; F Y Chang; H C Lin; R H Lu; C J Chu; S D Lee
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

3.  Variation in the risk for liver and gallbladder cancers in socioeconomic and occupational groups in Sweden with etiological implications.

Authors:  Jianguang Ji; Kari Hemminki
Journal:  Int Arch Occup Environ Health       Date:  2005-10-12       Impact factor: 3.015

4.  Autonomic dysfunction and cholelithiasis in patients with cirrhosis.

Authors:  A Chawla; L Puthumana; P J Thuluvath
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

5.  Cholelithiasis in cirrhotic patients from Turkey.

Authors:  A Dobrucali; S Hülagü; M Altin; I Dinç
Journal:  Dig Dis Sci       Date:  1994-02       Impact factor: 3.199

Review 6.  Gallstones in chronic liver disease.

Authors:  Michael Anthony Silva; Terence Wong
Journal:  J Gastrointest Surg       Date:  2005 May-Jun       Impact factor: 3.452

7.  Prospective study of the association of alcohol with cancer of the upper aerodigestive tract and other sites.

Authors:  I Kato; A M Nomura; G N Stemmermann; P H Chyou
Journal:  Cancer Causes Control       Date:  1992-03       Impact factor: 2.506

Review 8.  Gallstones in patients with liver cirrhosis: incidence, etiology, clinical and therapeutical aspects.

Authors:  Monica Acalovschi
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

9.  Gallbladder emptying, plasma levels of estradiol and progesterone, and cholecystokinin secretion in liver cirrhosis.

Authors:  M Pompili; G L Rapaccini; E Caturelli; D Curró; P Montuschi; M D'Amato; A Aliotta; A Grattagliano; A Cedrone; M Anti
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

10.  Gallbladder contractility in liver cirrhosis: comparative study in patients with and without gallbladder stones.

Authors:  Monica Acalovschi; Dan L Dumitrascu; Cezar D Nicoara
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.